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the complex structure of bile 
salt hydrolase from Lactobacillus 
salivarius reveals the structural 
basis of substrate specificity
fuzhou Xu1,2, Xiao-Jian Hu3, Warispreet Singh4, Wenjing Geng1, Irina G. Tikhonova4 & Jun Lin1
The gut bacterial bile salt hydrolase (BSH) plays a critical role in host lipid metabolism and energy 
harvest. Therefore, BSH is a promising microbiome target to develop new therapies to regulate obesity 
in humans and novel non-antibiotic growth promoters for food animals. We previously reported the 
1.90 Å apo crystal structure of BSH from Lactobacillus salivarius (lsBSH). In this study, we soaked the 
lsBSH crystal with glycocholic acid (GCA), a substrate, and obtained a 2.10 Å structure containing 
complex of lsBSH bound to GCA and cholic acid (CA), a product. The substrate/product sits in the water-
exposed cavity molded by Loops 2 and 3. While the glycine moiety of GCA is exposed into a highly polar 
pocket, the sterane core of GCA is stabilized by aromatic and hydrophobic interactions. Comparison 
of product binding with BSH from Clostridium perfringenes reveals a distinct orientation of the sterane 
core in the binding site. The stability of the substrate-lsBSH complex and the putative catalytic 
mechanism were explored with molecular dynamics simulations. Site-directed mutagenesis of lsBSH 
demonstrated that Cys2 and Asn171 are critical for enzymatic activity, while Tyr24, Phe65 and Gln257 
contribute to the substrate specificity. Together, this study provides structural insights into BSH-
substrate interaction, the mechanism of catalysis and substrate specificity, which facilitate rational 
design of BSH inhibitors.
The bile salt hydrolase (BSH) produced by intestinal bacteria catalyzes deconjugation of glyco-conjugated and 
tauro-conjugated bile acids through the hydrolysis of the amide bond and the release of free bile acids (e.g. cholic 
acid and chenodeoxycholic acid) and amino acids (glycine and taurine)1. Deconjugation is a gateway reaction in 
the metabolism of bile acids in the small intestine2,3. Therefore, BSH participates in a range of metabolic processes 
in mammalians including the regulation of dietary lipid absorption, cholesterol metabolism, energy and inflam-
mation homeostasis4–6. Modulation of BSH activity can affect host lipid metabolism, energy harvest and body 
weight gain, thus, is a promising strategy to control obesity in humans7,8 and to improve the growth performance 
in food animals2. Several BSH inhibitors showing a promise as animal growth promoters have been discovered in 
the high-throughput screening in our previous study9.
The BSH enzyme hydrolyses a substrate glycocholic acid (GCA) to product of cholic acid (CA) and glycine 
(Fig. 1). It is an N-terminal nucleophilic (Ntn) hydrolase10, which is known to undergo an autocatalytic cleav-
age of the N-terminal residue to expose the cysteine residue to act as a nucleophile11. Four crystal structures of 
BSH enzymes from Enterococcus faecalis (ef)12, Bifidobacterium longum (bl)13, Clostridium perfringenes (cp)14 and 
Lactobacillus salivarius (ls)15 are available in the literature. While the efBSH, blBSH and lsBSH are determined in 
the ligand-free form, the cpBSH complex with products, deoxycholate and taurine has provided the first struc-
tural basis of ligand interactions in BSH. Apart from the catalytic Cys2, the crystal structure of cpBSH indicates 
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that conserved Arg18, Asp21, Asn82 and Arg228 are important in catalysis and substrate binding14. However, the 
molecular basis of substrate recognition and mechanism of inhibition is still elusive.
The sequence identity among the four crystallized BSH isotypes is only 30–54%. Indeed, our previous lsBSH 
crystal structure highlighted differences in the loops surrounding the active site15. It is apparent that binding of 
substrates has distinct structural features in BSH isotypes. To investigate the variations in substrate specificity, we 
soaked lsBSH with the GCA substrate to obtain a crystal structure of the protein-ligand complex. Thus, we here 
report the first structure of the lsBSH-GCA-substrate complex and the structure of the lsBSH-CA-product com-
plex. The stability of the lsBSH-substrate complex and the putative catalytic mechanism were further explored 
in a molecular dynamics (MD) simulation study. We then validate the importance of several active site residues 
in substrate recognition and catalysis through mutagenesis and BSH activity analysis against six conjugated bile 
acids. Our work points into the molecular basis of substrate recognition and specificity in BSH isotypes.
Results
the overall structure of lsBSH bound to GCA or CA. The 2.1 Å X-ray crystal structure of lsBSH bound 
to GCA and CA was obtained by soaking apo lsBSH crystals in the crystallization buffer containing 5 µM GCA 
for 4 hours. The obtained crystal structure revealed two tetramers (chains A-D formed one tetramer and chains 
E-H formed another one) in one asymmetric unit (Figs 2 and S1). The crystallographic parameters of the GCA-
soaked lsBSH are shown in Table 1. Each lsBSH monomer contains two antiparallel β-sheets sandwiched between 
α-helices, adopting a four-layered αββα fold of the Ntn hydrolases. Further, the general tetrameric arrangement 
of monomers is consistent with the physiological assembly described for BSH12 and other Ntn hydrolase family 
members16,17. Apart from the N-terminus methionine residue, all amino acid residues of lsBSH were resolved in 
the crystal structure. The catalytic cysteine residue (Cys2) was found in the oxidized sulfonic form in all mono-
mers (Fig. 2). Structural comparison of the eight monomers revealed identical protein conformations with the 
average root-mean-square deviation (RMSD) of 0.38 Å over 237 Cα atoms.
The lsBSH monomers were obtained bound to substrate GCA or product CA (Fig. 2C,D), revealing that GCA 
has been hydrolyzed by the enzyme to CA and glycine during soaking experiments. In each lsBSH tetramer, only 
one monomer is in complex with GCA (chains A and F), while the remaining monomers are in complex with 
CA. The RMSD of GCA atoms in the active site is 2.27 Å between two superimposed lsBSH monomers of chains 
A and F (Fig. 2C). The large deviation is due to a different position of the glycine and 3-methylpropyl carboxyl 
moieties of GCA. In chain F, the carbon of the amide bond is at the distance of 4.9 Å to the sulphur atom of the 
catalytic cysteine, while in chain A, this distance is 8.1 Å and the glycine moiety is in a more solvent-exposed 
conformation. Interestingly, the monomer belonging to chain A contains a second GCA molecule at the vicinity 
of the active site (Fig. 2A,C).
The four CA molecules in chains B, D, G and H occupy an identical position with the average RMSD of 
0.43 Å, while the other two CA molecules of chains C and E are shifted towards a solvent exposed area with the 
average RMSD of 1.95 Å (Fig. 2D) to the cluster of four CA molecules. Comparison of GCA and CA positions 
in the lsBSH monomers shows that GCA of chain F and CA molecules of chains B, D, G and H have the smallest 
RMSD of 0.38 Å (Fig. 2E). The notable differences in positions of GCA and CA in several lsBSH monomers could 
be due to capturing different intermediate states of the ligands in the binding site or limitations of the soaking 
experiments.
Interactions of lsBSH with GCA and CA in the crystal structures. The active site in lsBSH is located 
in a shallow and water-exposed cavity formed by β-sheets and four loops, Loops 1–4 (Figs 2C and 3). Loops 2 
and 3 shape and partially close the active site of lsBSH from water exposure (Fig. 3). We chose the lsBSH complex 
bound to GCA from chain F to analyze the ligand-protein interactions since the glycine and 3-methylpropyl 
moieties of GCA occupy the catalytic site.
The glycine moiety of GCA points toward a highly polar area composed of Cys2, Arg16, Asp19, Asn79, 
Asn171, Arg224, Gln257 and Glu270 (Fig. 3A). The carboxyl group of the glycine moiety forms a H-bond with 
Asn79 and a water-mediated H-bond with Asn171. The amide bond of GCA is at the distance of 4.75 Å from 
the sulfur atom of the oxidized Cys2 (OCS-2). The NH-group of the GCA amide bond forms a H-bond with the 
backbone of Asp19 and the oxygen of OCS-2. In the case of four lsBSH monomers bound to CA (Chains B, D, G 
and H), the hydrolyzed carboxyl group is close to Asp19 and OCS-2 (Fig. 3B).
Figure 1. Chemical structure of GCA and CA. The carbons are numbered in GCA and the four rings (A–D) is 
marked in CA. The position of hydrolysis site (red line) is highlighted on the GCA molecule.
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The oxidized catalytic Cys2 is engaged in a network of polar interactions (Figs 3A and S1). The terminal amino 
group of Cys2 forms polar interactions with Asp19 and Asn171 and a water-mediated H-bond with Glu270. The 
carbonyl group of Cys2 has a H-bond with Arg224. The OCS-2 is engaged in polar interactions with Arg16, the 
backbone of Asp19 and Asn79, the side chain of Asn171 and through a water-mediated interaction with Glu270. 
Comparative sequence analysis shows that Arg16, Asp19, Asn79, Asn171 and Arg224 are conserved in BSH 
isotypes (Fig. S2).
In the crystal structure, a water molecule that forms water-mediated H-bonds with Asp19, Glu270 and Cys2 
(Figs 3A and S1) appears to facilitate the catalysis and hydration of the amide bond. The water molecule at the 
same position is also observed in the structure of lsBSH bound to CA, where it forms H-bonds with CA, OCS-2 
and Asn171 (Fig. 3B).
The sterane core of GCA and CA is in the hydrophobic pocket composed of Leu20 and Tyr24 from Loop 
1; Ile56 and Leu63 of Loop 2; Phe65 of the β-sheet; Leu134 and Phe130 of Loop 3; and Phe100 the α-helix top 
(Fig. 3). The α-surface of the sterane core faces Loop 3, whereas the β-surface of the sterane core that has two 
methyl groups faces Loops 1 and 2. The OH-group of sterane ring A forms a water-mediated H-bond with the 
backbone of Leu134, whereas the OH-group of sterane ring B forms a two-water-mediated H-bond with the 
side-chain of Trp141. This network of H-bonds is observed in both GCA- and CA- lsBSH complexes. The sterane 
core fits into the hydrophobic pocket, however, the pocket becomes hydrophilic the deeper it gets. Indeed, several 
water molecules are located at the bottom of the hydrophobic pocket in all lsBSH monomers, forming H-bonding 
with Tyr64, Pro99, Phe100, Ile103 and Trp141 (Fig. 3).
Comparison of crystal structures of lsBSH and cpBSH bound to catalytic reaction prod-
ucts. The crystal structure of cpBSH in the ligand-bound form, complexed with product deoxycholate, is 
available in the literature14. Superimposition of the cpBSH and lsBSH complexes shows that the orientation of 
the deoxycholate molecule in the cpBSH binding site is distinct from the positions of GCA or CA in the lsBSH 
binding site (Fig. 4). Thus, the α-face of the sterane core of deoxycholate is almost in the perpendicular orien-
tation relative to the α-face of the sterane core of GCA and has a one-ring shift towards a water-exposed area in 
cpBSH. The different position of the sterane core is due to different conformations of Loops 2 and 3 that change 
the size of the binding groove in cpBSH and lsBSH. In lsBSH, hydrophobic interactions between Ala58 of Loop 
2 and Leu134 of Loop3 pack the loops close to each other, pushing the sterane core of GCA and CA deeper to 
the binding groove (Fig. 4). In the case of cpBSH, the interactions between Loops 2 and 3 happen through bulky 
Figure 2. The overall structures of GCA-soaked lsBSH complex. (A) It consists of two tetramers, which are 
composed of chains A, B, C, D, E, F, G and H. In each lsBSH tetramer, one monomer is in complex with the 
substrate, GCA (in green), while the remaining monomers are in complex with the product, CA (in orange). 
(B) The tetramer structure formed by chains E, F, G and H. Each monomer has different color. (C) The 
superimposition of lsBSH monomers bound to GCA. GCA is in green from chain F and light green from 
chain A. The monomer of chain A contains the second GCA molecule at the vicinity of the active site. (D) The 
superimposition of lsBSH monomers bound to CA. CA is in orange from chains B, D, G and H and light orange 
from chains C and E. (E) The superimposition of lsBSH monomers bound to GCA and CA from chains F and B. 
The catalytic cysteine residue, Cys2 found in the oxidized form is shown in stick representation.
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Phe61 (corresponding to Ala58) and Ile137 (corresponding to Leu134), which hold the loops in a more open 
conformation, leaving a room to occupy a water-exposed hydrophobic pocket.
Other differences in the binding site of BSH isotypes are linked to Loop 1. In cpBSH, Loop 1 provides hydro-
phobic force to interact with the lateral of sterane. In particular, the benzene ring of Phe26, a main hydrophobic 
contact of Loop 1, restrains the lateral of the sterane core in the cpBSH binding groove. At the corresponding 
site in lsBSH, the phenol ring of Tyr24 flips up on 90 degrees and the major hydrophobic interaction comes 
from Phe65 (corresponding to Ala68 in cpBSH) that holds the lateral of the sterane (Fig. 4) in the lsBSH binding 
groove.
Refinement of the lsBSH-GCA complex with molecular dynamic simulations to reveal a cata-
lytic geometry. BSHs undergo an auto-catalytic post-translational modification, which makes the Cys res-
idue as the N-terminal residue10. The recent quantum mechanics and molecular mechanics (QM/MM) study of 
cpBSH in complex with tauro-deoxycholate has shown that Cys2 exists in the zwitterionic state, where the amino 
group is protonated and the thiol group is deprotonated11. This ionized state of Cys2 is stable by ~15 kcal/mol in 
comparison with the neutral form11. It appears that the conserved residues corresponding to Arg16, Asn79 and 
Asn171 in lsBSH are in the close proximity to Cys2 (2.7 Å) and reduces the pKa of the thiol group, making it eas-
ier to exist as a thiolate anion. Furthermore, the QM/MM study has also demonstrated that the thiolate anion of 
Cys2 performs a nucleophilic attack at the carbonyl carbon of the substrate amide bond. Taking advantage of the 
first lsBSH crystal structure in complex with the GCA substrate, we have further explored substrate interactions 
in the catalytic site in the presence of the Cys2 zwitterionic state using conventional atomistic MD simulations.
The superimposition of the lsBSH crystal structure and the MD simulation representative structure is shown 
in Fig. 5. The thiolate anion comes closer to the carbonyl of the amide bond with the average distance of 4.4 Å. 
The notable change, we observe, in the simulations is the flip of the carbonyl group of the amide bond from the 
solvent-exposed area towards Asn79 and Asn171 and formation of H-bonds with these residues (Fig. 5). In this 
position, the amide bond of the substrate establishes a catalytically productive conformation, where the carbonyl 
Data Collection and Processing
Space Group P21 (PDB ID 5Y7P)
Unit Cell 84.01, 94.09, 166.97, 90.0, 90.64, 90.0
Wavelength (Å) 1.5418
Resolution range (Å) 50.0–2.10 (2.14–2.10)
Completeness (%) 95.1 (89.7)
Mosaicity 0.947
I/σ (I) 12.7 (5.84)
Redundancy 5.3 (4.9)
Rmeas 0.078 (0.291)
Overall B factor from Wilson plot (Å2) 18.4
Refinement statistics
Resolution range (Å) 28.39–2.101 (2.176–2.101)
Unique reflections 143212 (13183)
Rwork/Rfree 0.1796/0.2195















  Most favoured (%) 96.64
  Allowed (%) 3.20
  Disallowed (%) 0.16
Table 1. Crystallographic parameters of the GCA-soaked lsBSH. Statistics for the highest-resolution shell are 
shown in parentheses.
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group is stabilized by interactions with the oxoanion hole residues (Fig. S3). This amide conformation is in agree-
ment with the proposed hydrolysis mechanism of the tauro-conjugated bile acid from the QM/MM study of 
lsBSH performed by Lodola et al.11.
The thiolate anion and the ammonium cation of Cys2 are stabilized by electrostatic interactions with Arg16 
and Asp19 and hydrogen bonds with Asn171 (Fig. S4). Mutations of residues in the corresponded positions in the 
Ntn hydrolases dramatically reduced the enzyme activity16. Overall, the glycine moiety of GCA has shifted deeper 
to the hydrophilic pocket of Cys2, Asn79, Asn171, Arg224 and Gln257 during the MD simulations.
In the simulations, several water molecules are often present in the vicinity of the amide bond of the substrate 
and the amino group of Cys2 (Fig. S5). Like in the hydrolysis of the amide bond in other Ntn hydrolases17, it is 
Figure 3. The lsBSH-GCA and lsBSH-CA complex structure. (A) Binding mode of GCA in the active site of 
lsBSH from Chain F. (B) Binding mode of CA in the active site of lsBSH from Chain B. The residues lining the 
active site are shown in stick representation. Oxygen atoms of water molecules within the active site are shown 
in red balls. GCA and CA are in green and orange, respectively. Loop 1 (residues: 21–26), Loop 2 (residues: 
56–63), Loop 3 (residues:127–138) and Loop 4 (residues: 257–268), lining the active site are shown in orange, 
yellow, cyan and pink, respectively. Distances of polar contacts in Å are shown in dashed black lines.
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expected that a water molecule initiates the deacylation step of the hydrolysis, where the amino group of Cys2 
abstracts a proton from the water molecule and the resultant hydroxyl anion then attacks the carbon of the car-
bonyl bond. The X-ray structure and the MD simulations are in good agreement with the hydrophobic interac-
tions made by the side chain of Leu18, Leu20, Tyr24, Ile56, Phe65, Leu134 and Leu139 with the GCA molecule 
(Fig. S6).
Figure 4. The superimposition of lsBSH and cpBSH active sites. The crystal structure of cpBSH in complex 
with deoxycholate, a product (PDB code: 2BJF) was used to superimpose with lsBSH bound to GCA, Chain 
F. Deoxycholate and GCA are in pink and green, respectively. The catalytic cysteine residue, Cys2 in the 
oxidized from is in stick representation. Loops 1–4 are shown in orange, yellow, cyan and pink, respectively. 
The non-conserved residues contributing to distinct substrate binding modes between lsBSH and cpBSH are 
shown in stick representation. Interactions between Ala58 of Loop 2 and Leu134 of Loop 3 in lsBSH and the 
corresponding pair of residues, Phe61 of Loop 2 and Ile137 of Loop 3 in cpBSH are shown in arrow dashed black 
lines. Hydrophobic interactions with Phe65 in lsBSH and Phe26 in cpBSH are shown in a dashed black line. 
A zoomed position of ligands is shown at the bottom right corner to highlight the distinct orientation of the 
sterane core in BSH isotypes. Amino acid residue labels in black and cyan are for lsBSH and cpBSH, respectively.
Figure 5. The superimposition of the lsBSH crystal structure and the molecular dynamics simulation 
representative structure. MD simulations of the crystal structure with Cys2 in the catalytically active 
zwitterionic state has been conducted to refine substrate interactions. In the simulations, the amide bond 
of GCA is pointed towards the oxoanion hole residues, Asn79 and Asn171 forming hydrogen bonds. GCA 
from the crystal structure and MD simulation conformations is in green and orange, respectively. The lsBSH 
crystal structure and MD conformation are in grey and pink, respectively. Cys2, Asn79 and Asn171 are in stick 
representation. Hydrogen bonds are in a dashed pink line. Distance between the carbon atom of the amide bond 
and the sulfur atom of Cys2 in Å are shown in a dashed black line.
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Enzymatic activity of BSH mutants against six conjugated bile acids. To further explore the con-
tribution of amino acid residues lining the active site of lsBSH to the catalysis and substrate binding we have 
performed site-directed mutagenesis of Cys2, Tyr24, Phe65, Asn171, Gln257 and Glu270 (Table 2). Cys2 and 
Asn171 were chosen to further confirm the Ntn hydrolase catalytic mechanism in lsBSH. Tyr24 and Phe65 were 
used to validate their role in the stabilization of the sterane ring, while Gln257 and Glu270 for the binding of the 
glycine moiety. Although Cys2 and Asn171 are fully conserved, the remaining residues vary in the BSH isotypes, 
thus likely contributing to substrate specificity (Fig. S2).
The constructed plasmids containing these mutations are shown in Table S1. The mutant BSH enzymes were 
purified from corresponding E. coli hosts and then analyzed by SDS-PAGE gel to demonstrate the high purity of 
the produced BSH mutants (Fig. S7). Circular dichroism analysis of the purified BSH enzymes indicated that all 
the mutant BSH enzymes including the Δ164–171 deletion mutant (Fig. S7) were still properly folded when com-
pared to the wild-type lsBSH (data not shown). Subsequently, the wild-type lsBSH and its mutants were subjected 
to BSH activity assay for six conjugated bile acids.
As expected, the mutation of Cys2 to serine completely knocks out the BSH activity towards all tested bile 
acids. The Cys2Ser mutant only displayed marginal BSH activity for TCA as compared to wild-type lsBSH 
(Table 2). The effect of Cys2Ser mutation in lsBSH further confirms that Cys2 is vital for the catalytic activity of 
BSH.
Mutation of Asn171 to alanine caused a dramatic decrease in the BSH activity for all six bile salts (Table 2). In 
particular, the enzyme activity for GCA, GDCA, GCDCA, and TDCA was substantially reduced compared to the 
wild-type lsBSH. The drastic effect of the Asn171Ala mutation was also expected as Asn171 forms a network of 
hydrogen bonding with GCA and stabilizes the tetrahedral intermediate as a part of the oxyanion hole (Fig. S3). 
Deletion of the adjacent residues of Asn171 (Δ164–171) completely abolished the BSH activity toward all tested 
bile acids (Table 2), highlighting the critical role of the region in BSH catalysis.
Replacement of Tyr24 with phenylalanine did not cause significant changes in BSH activity towards three 
tested tauro-conjugated bile acids (Table 2). However, the Tyr24Phe mutation led to significantly reduced hydrol-
ysis activity for the substrates of GCA and GDCA. Interestingly, this mutation resulted in a slight increase in BSH 
activity for GCDCA (Table 2). In the X-ray structure of lsBSH-GCA, the side chain of Tyr24 was 4.7 Å away from 
the hydroxyl group at position C12 of GCA. However, during the MD simulations, we observed the presence of 
water-mediated hydrogen bonds between the side chain of Tyr24 and the C12 hydroxyl group of the GCA mol-
ecule (Fig. S8A). The mutation of the Tyr24 to phenylalanine would have disrupted these hydrogen bonds and 
hence explains the decrease in the enzyme activity. On the contrary, GCDCA substrate that lacks the hydroxyl 
group at the C12 position would have been better stabilized by the presence of a hydrophobic Phe24 residue, 
hence improving its enzyme activity (Fig. S8B).
The mutation of Phe65 to Alanine abolished the BSH activity for GCA and GDCA but led to marginal activity 
for GCDCA (Table 2). This finding is consistent with the structural role of this residue in the stabilization of the 
sterane core. The enzyme activity of the Phe65Ala mutant for TCA and TDCA decreased by 40–50% compared 
to wild-type lsBSH, but for TCDCA was not affected (Table 2), suggesting a different contribution of Phe65 to the 
binding of tauro-conjugated bile salts.
The Gln257Ala mutation had a different effect on glycol-conjugated and tauro-conjugated bile salts. Thus, 
Gln257Ala mutation did not show a dramatic difference in tauro-conjugated bile salts (TCA, TDCA, TCDCA), 
but the activity for glycol-conjugated bile salts was decreased significantly (Table 2). Since Gln257 forms a hydro-
gen bond with Glu270 in the crystal structure, we created a double mutation of Gln257 and Glu270 to further 
validate the effect of Gln257 on substrate specificity. This double mutant caused a notable decrease of enzyme 
activity, ranging from 65% to 95%, for all six substrates relative to wild-type lsBSH. Notably, the Glu270Ala 
BSH
Relative BSH activitya
GCA GDCA GCDCA TCA TDCA TCDCA
WT 100 100 100 100 100 100
Cys2Ser — — — 3.02 — —
Tyr24Phe 79.17 71.43 118.59 100 100 100
Phe65Ala — — 3.70 64.15 52.73 101.89
Asn171Ala 7.08 3.57 4.07 10.75 4.73 16.41
Gln257Ala 25.17 16.49 13.87 98.44 96.21 93.13
Glu270Ala 159.86 79.38 103.65 100.78 104.55 102.29
Gln257Ala
Glu270Ala 27.21 11.34 6.93 35.16 11.36 16.79
Δ164–171 — — — — — —
Table 2. Comparison of BSH enzyme activity of various BSH mutants for different bile salts. aThe BSH activity 
was measured as µmol of amino acids released from the substrate per minute per mg of BSH (μmol/min/mg). 
The activity of following six bile salt substrates were tested: glycocholic acid (GCA), glycodeoxycholic acid 
(GDCA), glycochenodeoxycholic acid (GCDCA), taurocholic acid (TCA), taurodeoxycholic acid (TDCA), 
taurochenodeoxycholic acid (TCDCA). Experiments were carried out in triplicate. The numbers indicate the 
relative activity (%) of the activity of specific BSH mutant when comparing with that of wild-type BSH enzyme. 
“−” represents no significant difference when comparing with negative control.
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mutation alone did not cause significant difference in BSH activity towards all six substrates. These results sug-
gested that Gln257 and Glu270 contribute to the hydrolysis of bile salts and especially, Gln257 may play a differ-
ential role in glycol-conjugated and tauro-conjugated bile salt hydrolysis.
Discussion
We report here the first crystal structure of lsBSH in complex of a GCA substrate. It shows the binding environ-
ment of the substrate amino acid moiety and helps to map the catalytic mechanism of hydrolysis. In particular, the 
H-bond network involving the glycine moiety of the substrate and lsBSH residues: Cys2, Arg16, Asp19, Asn79, 
Asn171 and Arg224 highlights the importance of these residues for the catalysis. The MD simulation refinement 
of the crystal structure in the presence of the zwitterionic state of Cys2 further indicates that the carbonyl group 
of the GCA amide bond is engaged in hydrogen bonding with Asn79 and Asn171. Interactions with these resi-
dues are important to stabilize the carbonyl group of the amide bond during the hydrolysis (Fig. S3). Thus, the 
catalytic mechanism involves two steps: (1) the nucleophilic attack of the carbonyl carbon of the amide bond by 
the thiolate anion of Cys2 and the proton abstraction from the ionized amino group of Cys2 by the lone pair of 
the nitrogen of the amide bond; (2) and the deacylation of the enzyme with a help of a water molecule to form 
the neutral form of the N-terminal Cys2 and cholic acid (Fig. S3). Asn79 and Asn171 are proposed to form an 
‘oxyanion hole’ that stabilizes tetrahedral intermediate complexes in acylation and deacylation reactions (Fig. S3). 
Mutagenesis of Cys2 and Asn171 in this work and mutagenesis of Asn79 from literature confirm the essential role 
of these residues in the hydrolysis11.
The structure of lsBSH bound to GCA also is of help to begin an understanding of structural reasons of dif-
ferent substrate preferences in BSH isotypes. Here, we compared the ligand complex structures of lsBSH, with a 
broad substrate specificity and cpBSH, with a narrow substrate specificity and identified two reasons, which could 
affect the substrate binding profile. The first reason is due to the different position of the sterane ring of bile acids 
in the binding site. In lsBSH, Loop 3 makes the sterane ring to bind deeper to the groove due to more compact 
interactions with Loop 2. The non-conserved residues, Ala58 (Phe61 in cpBSH) in Loop 2 and Leu134 (Ile137 in 
cpBSH) in Loop 3 contribute to an inward conformation of Loop 3 in lsBSH and, therefore to the distinct orien-
tation of the α- and β-faces of the sterane core. In addition, we note that the sterane ring has a different pattern 
of hydrophobic interactions between lsBSH and cpBSH due to non-conserved residue Tyr24 (Phe26 in cpBSH) 
in Loop 1 and Phe65 (Ala68 in cpBSH) of the β-sheet. Mutation of Tyr24 and Phe65 in lsBSH demonstrates the 
contribution of these residues to substrate specificity.
Comparison of the lsBSH binding site with the efBSH and bsBSH structures shows that the position of Loop 
3 in efBSH is similar to lsBSH, whereas Loop 3 in bsBSH has, even more, a solvent-exposed conformation than 
cpBSH. It appears that the binding site of the sterane core in lsBSH and efBSH, both with a broad substrate spec-
trum12 has a similar shape and is distinct from the binding site of cpBSH and bsBSH with a narrow substrate 
spectrum14,15. It is expected that the orientation of the sterane core in the binding site varies in BSH isotypes 
contributing to a substrate binding profile.
The second reason is due to the binding pocket of a substrate amino acid moiety. In particular, Gln257 in 
lsBSH provides different substrate specificity upon mutation to alanine. This residue doesn’t form direct interac-
tions with GCA but forms an H-bond network with several residues of the pocket. Thus, mutation of this residue 
could change the H-bond network and subsequently the shape and hydrophilic property of the pocket, which 
affects differently the binding of glycol-conjugated and tauro-conjugated substrates. While Gln257 is conserved 
in lsBSH and efBSH, the residue at this position is methionine in cpBSH and blBSH, this further suggests the 
potential importance of this residue in substrate specificity (Fig. S2).
Phylogenetic analysis of BSH isotypes from various bacteria and with available substrate binding profile 
divides BSH isotypes into four clusters18. Interestingly, in each cluster, there are BSH isotypes with broad and 
narrow substrate specificity. The sequence alignment of several BSH isotypes (Fig. S2) with distinct substrate 
specificity shows low sequence identity and potential contribution of residues at various positions to substrate 
specificity in BSH isotypes. In this study, we have identified residues at several positions that are important for the 
substrate binding profile in lsBSH, providing the first structural basis of BSH substrate specificity. However, more 
efforts should be carried out in future to explore substrate specificity across different BSH isotypes. The structural 
information of substrate binding and specificity will facilitate a rational approach in the design of BSH inhibitors.
Materials and Methods
Bacterial strain, plasmid, and compound. Major bacterial strains and plasmids used in this study and 
their sources are listed in Table S1. Briefly, the E. coli recombinant strain JL885 containing pBSH expression vector 
(Table S1), constructed in our previous study19, was used for purification of wild-type lsBSH in this study. The 
pBSH plasmid bearing original bsh gene from L. salivarius NRRL B-30514 was used as parent vector for site-di-
rected mutagenesis. All compounds were purchased from Sigma-Aldrich (St. Louis, MO, USA), which include 
ampicillin, glycocholic acid (GCA), glycodeoxycholic acid (GDCA), glycochenodeoxycholic acid (GCDCA), tau-
rocholic acid (TCA), taurodeoxycholic acid (TDCA), taurochenodeoxycholic acid (TCDCA).
Macromolecule production and crystallization. The lsBSH protein was expressed, purified and crys-
tallized as described in our recent report15. After purification and concentration, 16 mg/ml lsBSH in the buffer 
consisting of 10 mM sodium acetate (pH5.5), 400 mM NaCl, 1 mM DTT, 1 mM EDTA, 10% (v/v) glycerol was 
crystallized in the crystallization buffer that is comprised of 20% (w/v) polyethylene glycol 3,350, 0.2 M KH2PO4 
(pH4.8) at 20 °C. To prepare soaking solution, GCA was dissolved in DMSO at the concentration of 100 mM and 
then the stock solution was diluted to final concentration of 10 mM using the crystallization buffer. Subsequently, 
to perform soaking experiment, one drop of 1.0 µl soaking solution was added beside the crystallization drop in 
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which the lsBSH crystals had grown 3–5 days; a thin line was drawn between two drops to allow GCA diffuse 
slowly into crystals. Following 4 hr of the interaction of the two drops, the soaked crystals were harvested and 
flash frozen in crystallization buffer with additional 25% glycerol for diffraction experiment.
Data collection and processing. The apo lsBSH-substrate complex crystal was flash frozen in the crystal-
lization buffer with additional 25% glycerol as cryoprotectant and the diffraction data were collected at Biortus 
company (Jiangyin, China) with a home source diffraction system of Rigaku F-RE++/Saturn 944 CCD. Molecular 
replacement was performed with PHASER20 using our apo-lsBSH (PDB ID 5HKE) as an initial searching model. 
Structure refinement was performed with PHENIX21, REFMAC22, CCP4 Package23 and COOT24. The structures 
were drawn using Maestro 2018-425 and PyMol26. The atomic coordinate and structure factor has been deposited 
in the Protein Data Bank (PDB ID 5Y7P).
Site-directed amino acid substitution mutagenesis. The specific amino acid or region was mutated 
using QuickChange II site-directed mutagenesis kit (Agilent Technologies, USA). Briefly, the partial overlapping 
primer pairs containing the desired mutations (Table S2) were used for PCR amplification with the pBSH plasmid 
as template. The cycling conditions were as follows: 95 °C for 30 sec, followed by 12–18 cycles at 95 °C for 30 sec, 
55 °C for 1 min, and 68 °C for 6.5 min, and finally at 4 °C. The PCR products were treated with DpnI at 37 °C for 
1 hr to digest the methylated, non-mutated parental DNA template. The digested products were transformed 
into XL1-Blue super competent cells and cell cultures were grown on LB agar plates with ampicillin (100 μg/ml). 
Plates were incubated at 37 °C overnight. In the following steps, single colony was incubated for plasmid DNA 
extraction. The recombinant plasmid with a specific amino acid substitution in pBSH was verified by sequencing 
(University of Tennessee Genomic Core). Total eight plasmids with different amino acids substitutions or deletion 
were generated and then transformed into E. coli BL21(DE3) competent cells to create the constructs producing 
BSH mutants (Table S1). These constructs and the control strain JL885 were used for purification of recombinant 
BSH enzymes as detailed in our recent publication15. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) with a 12% (w/v) polyacrylamid separating gel was performed to monitor production and purifica-
tion of the rBSH. The purified rBSH was finally dialyzed against PBS buffer containing 10% of glycerol and 5 mM 
of L-glutathione (pH 7.0). To determine if the BSH mutants are natively folded, circular dichroism experiment 
was performed using Aviv 202 CD spectrophotometer in Bioanalytical Resource Facility at The University of 
Tennessee (Knoxville, USA). The rBSH aliquots were stored in −80 °C freezer prior to use. Protein concentration 
was measured by BCA protein assay kit (Pierce).
BSH activity assay. The wild-type lsBSH and corresponding mutants were subjected to the two-step standard 
BSH activity assays as described previously11,16 with brief modification. Briefly, 10 μl of purified BSH enzyme (1 µg/
µl), 10 μl of conjugated bile salt (GCA, GDCA, GCDCA, TCA, TDCA, or TCDCA), 178 µl of reaction buffer (0.1 M 
sodium-phosphate, pH 6.0), and 2 μl of 1 M DTT were mixed gently and incubated at 37 °C for 30 min. Following 
the incubation, reaction tubes were put on ice to stop the reaction. Then, 50 µl aliquot of the reaction mixture was 
mixed with 50 µl 15% trichloroacetic acid (w/v) to fully stop the reaction, and the sample was centrifuged at 12,000 g 
for 5 min to remove the precipitate. The supernatant was mixed thoroughly with 950 μl ninhydrin reaction mix 
(250 μl of 1% ninhydrin [w/v], 100 μl of 0.5 M sodium-citrate buffer [pH5.5], and 600 μl of glycerol) and incubated 
in boiling water for 14 min. The reactions were stopped by putting reaction tubs on ice for 3 min and the absorbance 
of reaction mix at 570 nm wavelength was measured using Smart Spec Plus spectrophotometer (Bio-Rad). Standard 
curves using glycine or taurine were determined for each independent assay. All assays were performed in triplicate. 
Enzyme activity was expressed as 1 μmol of amino acids released from substrates per minute per mg of BSH19 and 
mutants relative activity compared to wild-type lsBSH was also calculated. Comparison of enzyme activity between 
mutants was tested by ANOVA. Levels of significance for P value were 5% (0.05). The statistical analysis was per-
formed using SAS software (v9.03, SAS Institute Inc., Cary, NC). Relative activity (%) was calculated by dividing the 
mean activity of specific BSH mutant to the mean activity of wild-type BSH and then multiplied by 100.
Molecular dynamics simulations. Chain F of the lsBSH-GCA complex (PDB code: 5Y7P) was used to 
perform MD simulations. The protonation states of the titrable residue in the crystal structure of the lsBSH in 
complex with GCA were assigned using the H++ server27 at pH 6.0. The side chain of Cys2 residue was set in the 
zwitterionic state based on the previous literature11. The parameters of GCA were developed using Antechamber 
of Amber Tools 16.
The productive MD simulations was run in the NPT ensemble at 310 K for 50 ns using the GPU version of the 
PMEMD engine28 integrated with the Amber 16 package29. The AMBER-FB15 force field30 was used in the simu-
lations. The TIP3P31 water model and 10 Na + ions were used to solvate the lsBSH-GCA complex using an octahe-
dral box. The entire system was first subjected to energy minimization using the steepest descent method followed 
by the conjugate gradient algorithm for total of 4000 steps. The system was then subjected to the controlled 
heating from 0 to 310 K using a Langevin thermostat with a collision frequency of 1 ps−1 using a NVT ensemble 
for 400 ps. The protein and the GCA molecule were restrained using a harmonic potential of 50 kcal mol−1 Å 
during the heating cycle. The density and the dimension of the entire system was equilibrated using the NPT 
ensemble for 1 ns. The Berendsen barostat was used to maintain the pressure at 1 bar during the equilibration 
phase. The production MD was run in the NPT ensemble for 50 ns. The SHAKE algorithm was used to constrain 
all the bonds with hydrogen atoms32. The periodic boundary conditions were used with a cutoff radius of 8 Å and 
electrostatic energy calculations were performed using the particle mesh Ewald (PME) method33. The individual 
frames were saved every 20 ps during the production run. CPPTRAJ34 and VMD35 were used to analyze the MD 
trajectory. The images were made using Maestro 2018-425 and UCSF Chimera36.
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